Annual Meeting

Out with the old, in with the nucleus

Learn about the Discover BMB 2024 symposium on signaling mechanisms in the nucleus
Glen Liszczak Aaron Johnson
By Glen Liszczak and Aaron Johnson
Sept. 21, 2023

Are you tired of binging reruns on Netflix?  Maybe you need a break from reality TV but you’re not sure where to turn for high-quality entertainment?  Look no further — the nucleus has it all.  There’s mystery, murder, machines of extraordinary complexity and visually stunning landscapes. 

Stories in nuclear signaling are unraveling at an unprecedented pace thanks to technological and conceptual advances in chemistry, biochemistry and cell biology. Our speakers will address long-standing questions about organism development, cellular identity and the genetic basis for disease. 

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

You will hear about how cutting-edge interdisciplinary approaches are being used to uncover new regulatory mechanisms underlying transcription, genome structure, and other phenomena in the nucleus. We will also discuss how rapid progress in the field is inspiring new therapeutic approaches for diseases related to dysfunctional nuclear processes.

You don’t want to miss this — even the cytosol junkies will be on the edge of their seats.

Keywords:  Enzyme mechanism, genetics and disease, chemical probes, transcription regulation, chromatin modifications, genome structure.

Who should attend: You. Our speakers span a wide breadth of biological phenomena, scientific disciplines and technologies. We have something for everyone. Current projections: standing room only.

Your session’s theme song“Journey to the Island” by John Williams

This song is about the most important genetics experiment ever performed.

This session is powered by “hot, nasty, bad-*ss speed.” — Eleanor Roosevelt, Talladega Nights

Signaling mechanisms in the nucleus

Chemical strategies to study nuclear processes

Chair: Aaron Johnson

Anna MappUniversity of Michigan

Glen LiszczakUniversity of Texas Southwestern Medical Center

Oliver BellUniversity of Southern California Kerk School of Medicine

Minkui LuoMemorial Sloan Kettering Cancer Center

Chromatin organization, replication and repair

Chair: Katharine Diehl

Aaron StreetsUniversity of California, Berkeley

Aaron JohnsonUniversity of Colorado Anschutz Medical Campus

Carl WuJohns Hopkins University

Serena Sanulli, Stanford University

Chromatin modifications in the nucleus

Chair: Glen Liszczak

Alex RuthenbergUniversity of Chicago

Katharine DiehlUniversity of Utah

Tim StasevichColorado State University

Phil ColeHarvard University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Glen Liszczak
Glen Liszczak

Glen Liszczak is an assistant professor in the biochemistry department at the University of Texas Southwestern Medical Center.

Aaron Johnson
Aaron Johnson

Aaron Johnson is an associate professor in the biochemistry and molecular genetics department at the University of Colorado School of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Journal News

How antigen-processing proteins shape immunity

Nov. 6, 2025

Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Journal News

New chemical strategy boosts accuracy in proteomics

Nov. 6, 2025

Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
Profile

Understanding the roles of extracellular matrix and vesicles in valvular disease

Oct. 30, 2025

MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Oct. 29, 2025

Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Journal News

Serum lipids may predict early diabetes risk

Oct. 29, 2025

Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.